Hidradenitis suppurativa. Hidradenitis suppurativa
Conditions
Interventions
Intervention 1: Intervention group: An alcohol spray and betadine will clean and sterilize the affected area before the procedure, and a local injection of a 2% lidocaine ampoule will provide anesthes
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with moderate to severe cases (Hurley Stage) of HS disease according to clinical evidence Having Informed consent to participate in the study Age above 18 years old
Exclusion criteria
Exclusion criteria: Patients with active infection at the procedure site Patients allergic to anesthetics Patients with a cardiac pacemaker Patients with metallic implants Pregnant and lactating women Patients with unilateral lesions Receiving anticoagulant and antiplatelet drugs Performing surgery at the procedure site Patients with underlying autoimmune disease, malignancy and immunodeficiency Phobia about treatment with RF
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing the recovery of lesions from the doctor's point of view. Timepoint: Start studying, the end of the second, fourth and eighth weeks. Method of measurement: Impression of improvement (CGI-I).;Overall improvement rate from the patient's point of view. Timepoint: Start studying, the end of the second, fourth and eighth weeks. Method of measurement: Patient global impression of improvement(PGA).;Assessment of recovery process. Timepoint: Start studying, the end of the second, fourth and eighth weeks. Method of measurement: Using HiSCR Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Zahra Shiravani
Shiraz University of Medical Sciences
Outcome results
None listed